CIK 0001763950
- Non-accelerated filer
- Smaller reporting company
Lantern Pharma Inc.
Sign in to watch- Ticker
- LTRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- Operating
- EIN
- 463973463
- Phone
- +1 972-277-1136
- Business address
- 1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS, TX, 75201
- Former names
- Lantern Pharma
- 4 Open-market sale 10% owner sold 61,613 shares at an average $3.38 ($208,271)
- 4 Open-market sale 10% owner sold 56,237 shares at an average $2.99 ($168,419)
- 4 Open-market sale 10% owner sold 56,237 shares at an average $2.99 ($168,419)
- 4 Option exercise Director acquired 3,832 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 30,000 shares at an average $6.30 ($189,100)
- 4 Open-market sale 10% owner sold 30,000 shares at an average $6.30 ($189,100)
- 4 Open-market sale 10% owner sold 144,000 shares at an average $4.70 ($676,294)
- 4 Open-market sale 10% owner sold 144,000 shares at an average $4.70 ($676,294)
- 4 Open-market sale 10% owner sold 58,889 shares at $4.20 ($247,334)
- 4 Open-market sale 10% owner sold 58,889 shares at $4.20 ($247,334)
- 4 Open-market sale 10% owner sold 145,348 shares at $3.44 ($499,997)
- 4 Open-market sale 10% owner sold 145,348 shares at $3.44 ($499,997)
- 4 Open-market sale 10% owner sold 350,000 shares at $4.40 ($1,540,000)
Page 2 of 4 · 79 filings